Published in Neurocrit Care on October 01, 2012
Controversies in defining and determining death in critical care. Nat Rev Neurol (2013) 1.08
Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med (2010) 5.41
Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med (2010) 4.61
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med (2004) 4.24
Association between blood lactate levels, Sequential Organ Failure Assessment subscores, and 28-day mortality during early and late intensive care unit stay: a retrospective observational study. Crit Care Med (2009) 3.83
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med (2014) 3.37
Prediction of potential for organ donation after cardiac death in patients in neurocritical state: a prospective observational study. Lancet Neurol (2012) 2.95
Euthanasia in intensive care: a 56-year-old man with a pontine hemorrhage resulting in a locked-in syndrome. Crit Care Med (2007) 2.87
The Eldicus prospective, observational study of triage decision making in European intensive care units. Part II: intensive care benefit for the elderly. Crit Care Med (2012) 2.46
The relation of near-infrared spectroscopy with changes in peripheral circulation in critically ill patients. Crit Care Med (2011) 2.37
Blood lactate monitoring in critically ill patients: a systematic health technology assessment. Crit Care Med (2009) 2.21
Protection against renal ischemia-reperfusion injury by ischemic postconditioning. Transplantation (2013) 2.17
Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. Acta Oncol (2006) 2.16
Cost effectiveness of laparoscopic versus mini-incision open donor nephrectomy: a randomized study. Transplantation (2007) 2.05
Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial. Intensive Care Med (2003) 2.05
Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol (2010) 1.91
The prognostic value of blood lactate levels relative to that of vital signs in the pre-hospital setting: a pilot study. Crit Care (2008) 1.85
Persistent peripheral and microcirculatory perfusion alterations after out-of-hospital cardiac arrest are associated with poor survival. Crit Care Med (2012) 1.78
Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics (2004) 1.73
End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells. Nephrol Dial Transplant (2009) 1.71
Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol (2013) 1.68
International study on microcirculatory shock occurrence in acutely ill patients. Crit Care Med (2015) 1.64
Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy? Ann Surg Oncol (2011) 1.63
Microvascular perfusion as a target for fluid resuscitation in experimental circulatory shock. Crit Care Med (2014) 1.63
The Eldicus prospective, observational study of triage decision making in European intensive care units: part I--European Intensive Care Admission Triage Scores. Crit Care Med (2012) 1.59
Preoperative fasting protects mice against hepatic ischemia/reperfusion injury: mechanisms and effects on liver regeneration. Liver Transpl (2011) 1.59
CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14). Crit Care Med (2004) 1.58
Glucose supplementation does not interfere with fasting-induced protection against renal ischemia/reperfusion injury in mice. Transplantation (2011) 1.57
Noninvasive monitoring of peripheral perfusion. Intensive Care Med (2005) 1.54
ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption. Transpl Int (2014) 1.53
Organ donations and unused potential donations in traumatic brain injury, subarachnoid haemorrhage and intracerebral haemorrhage. Intensive Care Med (2006) 1.53
Re-thinking resuscitation: leaving blood pressure cosmetics behind and moving forward to permissive hypotension and a tissue perfusion-based approach. Crit Care (2013) 1.50
The use of opioids and sedatives and time until death after withdrawing mechanical ventilation and vasoactive drugs in a dutch intensive care unit. Anesth Analg (2011) 1.48
Altruistic living kidney donation challenges psychosocial research and policy: a response to previous articles. Transplantation (2005) 1.44
What to do when a competent ICU patient does not want to live anymore but is dependent on life-sustaining treatment? Experience from The Netherlands. Intensive Care Med (2010) 1.43
External validation of a prognostic model predicting time of death after withdrawal of life support in neurocritical patients. Crit Care Med (2012) 1.43
Direct cost analysis of intensive care unit stay in four European countries: applying a standardized costing methodology. Value Health (2012) 1.42
The β-human chorionic gonadotropin-related peptide LQGV reduces mortality and inflammation in a murine polymicrobial sepsis model. Crit Care Med (2011) 1.42
Use of a peripheral perfusion index derived from the pulse oximetry signal as a noninvasive indicator of perfusion. Crit Care Med (2002) 1.41
The effect of goal-directed therapy on mortality in patients with sepsis - earlier is better: a meta-analysis of randomized controlled trials. Crit Care (2014) 1.35
Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer. Hepatology (2012) 1.33
Prevalence and incidence of severe sepsis in Dutch intensive care units. Crit Care (2004) 1.33
Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology (2011) 1.29
Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J (2012) 1.27
The prognostic value of the subjective assessment of peripheral perfusion in critically ill patients. Crit Care Med (2009) 1.24
Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients. Transplantation (2009) 1.22
Live donor nephrectomy: a review of evidence for surgical techniques. Transpl Int (2009) 1.17
The choice of anatomical site for islet transplantation. Cell Transplant (2008) 1.17
KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue. Int J Cancer (2013) 1.16
Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med (2008) 1.16
Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation. Stem Cells Dev (2010) 1.16
Imminent brain death: point of departure for potential heart-beating organ donor recognition. Intensive Care Med (2010) 1.16
The impact of severe sepsis on health-related quality of life: a long-term follow-up study. Anesth Analg (2008) 1.15
Implications of ICU triage decisions on patient mortality: a cost-effectiveness analysis. Crit Care (2011) 1.14
Colistin, SDD and resistance: nihil novi sub sole. Intensive Care Med (2014) 1.13
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics. Intensive Care Med (2015) 1.12
Prognostic value of blood lactate levels: does the clinical diagnosis at admission matter? J Trauma (2009) 1.11
Deferred proxy consent in emergency critical care research: ethically valid and practically feasible. Crit Care Med (2009) 1.11
Effects of Hypoxia on the Immunomodulatory Properties of Adipose Tissue-Derived Mesenchymal Stem cells. Front Immunol (2013) 1.11
Clinical review: Clinical imaging of the sublingual microcirculation in the critically ill--where do we stand? Crit Care (2012) 1.11
Quality of life on admission to the intensive care: can we query the relatives? Intensive Care Med (2003) 1.10
Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients. Intensive Care Med (2010) 1.10
Complex vascular anatomy in live kidney donation: imaging and consequences for clinical outcome. Transplantation (2008) 1.09
Don't take vitals, take a lactate. Intensive Care Med (2007) 1.09
The brain is not dead when the cortex is dead. Crit Care Med (2015) 1.08
Low tissue oxygen saturation at the end of early goal-directed therapy is associated with worse outcome in critically ill patients. Crit Care (2009) 1.08
Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). Transplantation (2010) 1.07
Assessment of tissue oxygen saturation during a vascular occlusion test using near-infrared spectroscopy: the role of probe spacing and measurement site studied in healthy volunteers. Crit Care (2009) 1.07
Quality of life before intensive care unit admission is a predictor of survival. Crit Care (2007) 1.05
Electrical impedance tomography measured at two thoracic levels can visualize the ventilation distribution changes at the bedside during a decremental positive end-expiratory lung pressure trial. Crit Care (2011) 1.04
Experiences of critically ill patients in the ICU. Intensive Crit Care Nurs (2008) 1.03
Lung volume calculated from electrical impedance tomography in ICU patients at different PEEP levels. Intensive Care Med (2009) 1.02
Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy. Ann Surg Oncol (2011) 1.01
Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl (2003) 0.99
Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatol Int (2012) 0.99
Laparoscopic donor nephrectomy: a plea for the right-sided approach. Transplantation (2009) 0.99
Late onset of development of natural anti-nonGal antibodies in infant humans and baboons: implications for xenotransplantation in infants. Transpl Int (2007) 0.98
Clinical review: Circulatory shock--an update: a tribute to Professor Max Harry Weil. Crit Care (2012) 0.97
Hepatocellular adenoma: cost-effectiveness of different treatment strategies. Radiology (2009) 0.97
Psychosocial and physical impairment after mini-incision open and laparoscopic donor nephrectomy: A prospective study. Transplantation (2006) 0.97
Medications for analgesia and sedation in the intensive care unit: an overview. Crit Care (2008) 0.97
The heterogeneity of the microcirculation in critical illness. Clin Chest Med (2008) 0.97
Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI. J Magn Reson Imaging (2012) 0.97
Understanding venous return. Intensive Care Med (2014) 0.96
Inability to obtain deferred consent due to early death in emergency research: effect on validity of clinical trial results. Intensive Care Med (2010) 0.95
A microcosting study of intensive care unit stay in the Netherlands. J Intensive Care Med (2008) 0.94
Differential expression of heme oxygenase-1 and vascular endothelial growth factor in cadaveric and living donor kidneys after ischemia-reperfusion. J Am Soc Nephrol (2003) 0.93
Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy. Stem Cells Dev (2012) 0.93
Randomized controlled trial comparing hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy. Transplantation (2014) 0.93
Safety and efficacy of radiofrequency ablation for hepatocellular adenoma. J Vasc Interv Radiol (2011) 0.92
Fluid resuscitation in ICU patients: quo vadis? Intensive Care Med (2015) 0.92
Comparison of macroscopic pathology measurements with magnetic resonance imaging and assessment of microscopic pathology extension for colorectal liver metastases. Int J Radiat Oncol Biol Phys (2010) 0.92
Culture expansion induces non-tumorigenic aneuploidy in adipose tissue-derived mesenchymal stromal cells. Cytotherapy (2013) 0.91
Ethnically diverse populations and their participation in living kidney donation programs. Transplantation (2010) 0.91
Management of hepatocellular adenoma during pregnancy. J Hepatol (2010) 0.91
Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors. Int J Radiat Oncol Biol Phys (2007) 0.91
Psychological barriers for living kidney donation: how to inform the potential donors? Transplantation (2007) 0.91